13342 Berlin, de
+49-30-468 124 31
Schering’s stockholders to resolve on domination and profit and loss transfer agreement with Bayer
Election of new investor representatives to the Supervisory Board / Renaming to “Bayer Schering Pharma Aktiengesellschaft”
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to firstname.lastname@example.org.